Evidence map›Paper›PMID 35785027›Full record

ArticleJournal of immunology research2022

Role of CD

Weilin Xue, Jianying Ma, Yue Li, Chunxia Xie

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Association betweenFrontiers in immunology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. The Mediation of Circulating Inflammatory Proteins in the Causal Pathway from Immune Cells to COPD.International journal of chronic obstructive pulmonary disease · 2025
    Article
  12. Review
  13. IL-6 and CD4Journal of inflammation research · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Weilin XueDepartment of Respiratory Medicine, Qingdao Hiser Medical Center, Qingdao, 266033 Shandong Province, China.
Jianying MaDepartment of General Medicine, Qingdao Hiser Medical Center, Qingdao, 266033 Shandong Province, China.
Yue LiDepartment of Respiratory Medicine, Qingdao Hiser Medical Center, Qingdao, 266033 Shandong Province, China.
Chunxia XieDepartment of Respiratory Medicine, Qingdao Hiser Medical Center, Qingdao, 266033 Shandong Province, China.ORCID https://orcid.org/0000-0003-3886-7948
Qingdao Center of Resource Chemistry and New Materials · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work was to explore the changes of T lymphocyte subsets in peripheral blood of patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) (AECOPD) and the role of cellular immunity mediated in the disease process. Eighty-six patients with AECOPD who visited Qingdao Hiser Medical Center from June 2020 to December 2021 and 30 healthy people (controls) who underwent health examination in the same period were selected. The differences of pulmonary function (PF), arterial blood gas (ABG), blood routine inflammatory indexes, T lymphocyte and T lymphocyte subsets were compared between the two groups, and the correlation between T lymphocyte subsets and each index was analyzed. There were clear differences in PF, ABG, and PB inflammation indexes between AECOPD patients and the controls (

Indexed as

Pulmonary Disease, Chronic ObstructiveHumansImmunity, CellularLungLymphocyte CountT-Lymphocyte Subsets

Identifiers

PMID35785027
PMCPMC9242747
OpenAlexW4283328351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.